Holen Sie sich die Stockscreener-App
231.69
0.47%
-1.10
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RMD?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$232.79
Offen:
$232.31
24-Stunden-Volumen:
499.15K
Relative Volume:
0.62
Marktkapitalisierung:
$34.04B
Einnahmen:
$4.93B
Nettoeinkommen (Verlust:
$1.25B
KGV:
27.35
EPS:
8.47
Netto-Cashflow:
$1.38B
1W Leistung:
-0.55%
1M Leistung:
-6.50%
6M Leistung:
+3.29%
1J Leistung:
+28.51%
1-Tages-Spanne:
$230.34
$233.38
1-Wochen-Bereich:
$228.87
$240.00
52-Wochen-Spanne:
$170.56
$263.05
Resmed Inc Stock (RMD) Company Profile
Firmenname
Resmed Inc
Sektor
Telefon
(858) 746-2400
Adresse
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Vergleichen Sie RMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
231.69 | 34.04B | 4.93B | 1.25B | 1.38B | 8.47 |
|
ISRG
Intuitive Surgical Inc
|
591.79 | 211.07B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.43 | 65.30B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.31 | 44.67B | 9.76B | 1.16B | 665.00M | 2.34 |
|
COO
The Cooper Companies, Inc.
|
88.48 | 17.62B | 3.90B | 392.30M | 288.10M | 1.95 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-16 | Eingeleitet | Goldman | Buy |
| 2025-01-10 | Eingeleitet | Piper Sandler | Neutral |
| 2024-12-13 | Eingeleitet | Stifel | Hold |
| 2024-09-24 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-09-18 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | Herabstufung | Needham | Buy → Hold |
| 2024-06-25 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-06-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | Hochstufung | Needham | Hold → Buy |
| 2023-09-05 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | Eingeleitet | UBS | Buy |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-01-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-10-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-09-08 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-08-15 | Herabstufung | CLSA | Buy → Outperform |
| 2022-08-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-08-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-01-31 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-31 | Hochstufung | Goldman | Neutral → Buy |
| 2022-01-28 | Hochstufung | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-24 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-01-13 | Hochstufung | CLSA | Outperform → Buy |
| 2022-01-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | Hochstufung | Macquarie | Neutral → Outperform |
| 2021-10-22 | Hochstufung | CLSA | Underperform → Outperform |
| 2021-08-02 | Herabstufung | CLSA | Outperform → Sell |
| 2021-08-02 | Herabstufung | Needham | Buy → Hold |
| 2021-07-28 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-07-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-14 | Eingeleitet | RBC Capital Mkts | Underperform |
| 2021-06-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-06-22 | Hochstufung | Macquarie | Neutral → Outperform |
| 2021-06-22 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-06-21 | Bestätigt | Needham | Buy |
| 2021-06-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-06-09 | Hochstufung | CLSA | Sell → Outperform |
| 2021-05-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-04-30 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-03-16 | Hochstufung | Needham | Hold → Buy |
| 2020-11-02 | Hochstufung | UBS | Neutral → Buy |
| 2020-10-30 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-10-27 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-08-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-05-01 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | Eingeleitet | CLSA | Underperform |
| 2020-01-31 | Herabstufung | UBS | Buy → Neutral |
| 2020-01-10 | Eingeleitet | Oppenheimer | Perform |
| 2019-11-22 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | Hochstufung | UBS | Neutral → Buy |
| 2019-07-16 | Herabstufung | UBS | Buy → Neutral |
| 2019-05-06 | Hochstufung | UBS | Neutral → Buy |
| 2019-04-18 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-01-25 | Herabstufung | Goldman | Buy → Neutral |
| 2019-01-25 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | Eingeleitet | Goldman | Buy |
Alle ansehen
Resmed Inc Aktie (RMD) Neueste Nachrichten
6,300 Shares in ResMed Inc. (NYSE:RMD) Acquired by Hussman Strategic Advisors Inc. - MarketBeat
Ieq Capital LLC Grows Stock Position in ResMed Inc. (NYSE:RMD) - MarketBeat
Alberta Investment Management Corp Acquires Shares of 10,400 ResMed Inc. (NYSE:RMD) - MarketBeat
Pittenger & Anderson Inc. Has $14.30 Million Position in ResMed Inc. (NYSE:RMD) - MarketBeat
3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD) - MSN
ResMed (NYSE:RMD) Shares Gap UpHere's Why - MarketBeat
Cumberland Partners Ltd Acquires 11,000 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
Convergence Investment Partners LLC Invests $1.03 Million in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Shares Purchased by Asset Management One Co. Ltd. - MarketBeat
Chevy Chase Trust Holdings LLC Sells 1,752 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
AustralianSuper Pty Ltd Increases Position in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Shares Sold by Congress Asset Management Co. - MarketBeat
Assistive Technology Market Is Booming Worldwide 2025-2032: Permobil AB, Sunrise Medical LLC., Tobii AB, - EIN News
ResMed (NYSE:RMD) Stock Unloaded Rep. Robert Bresnahan, Jr. - MarketBeat
Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 26%? - Yahoo Finance
Nations Financial Group Inc. IA ADV Acquires New Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
Entropy Technologies LP Sells 6,581 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
Empowered Funds LLC Has $2.77 Million Stock Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
Rhumbline Advisers Sells 13,536 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Holdings Lifted by Van ECK Associates Corp - MarketBeat
Banque Pictet & Cie SA Takes Position in ResMed Inc. (NYSE:RMD) - MarketBeat
Kestra Private Wealth Services LLC Buys 4,702 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
Here's Why ResMed (RMD) Could be Great Choice for a Bottom Fisher - MSN
ResMed Inc.'s (NYSE:RMD) Share Price Not Quite Adding Up - Simply Wall St
ResMed Updates Dividend Exchange Rate for CDI Holders - TipRanks
ResMed Inc. stock rises Thursday, outperforms market - MarketWatch
ResMed Inc. Reports Changes in CDI and Security Issuances - MSN
ResMed Close To Joining Very Elite Stock Group - MSN
Earnings call transcript: ResMed surpasses Q2 FY2025 earnings forecast, stock dips - MSN
State of Alaska Department of Revenue Decreases Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Shares Sold by Stephens Inc. AR - MarketBeat
ResMed Inc. (NYSE:RMD) Stake Lowered by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Mirae Asset Global Investments Co. Ltd. Buys 3,576 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
Stephens Investment Management Group LLC Has $76.04 Million Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Holdings Lowered by Tobam - MarketBeat
Insider Sell: Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD) - GuruFocus.com
ResMed CFO Executes Planned Stock Transaction - TipRanks
ResMed CEO Executes Strategic Stock Transactions - TipRanks
ResMed Getting Closer To Key Technical Benchmark - MSN
Ex-Dividend Reminder: TJX Companies, UNITIL and ResMed - Nasdaq
Down 4%, is the ResMed share price in the buy zone? - MSN
Research Analysts Issue Forecasts for ResMed Q3 Earnings - MarketBeat
Resmed Chief Financial Officer Sells 1,000 Shares -February 10, 2025 at 06:33 pm EST - Marketscreener.com
Here's why I invested MORE money in ResMed shares last week - MSN
Finanzdaten der Resmed Inc-Aktie (RMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.83%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):